RxDoctor Payments Data

Catherine Salsberry

Family · Rock Island, ILNPI 1679129985

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $18,700 of the $22,485 with a category attached, or 83.2%. AbbVie accounts for 90.2% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $12,965 and has fallen 51.3% since, to $6,312 in 2025. Among family clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,485in general payments, 2019–2025

Across 171 payments — averaging $131.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$20K
  • Supernus Pharmaceuticals, Inc.$442
  • Alkermes, Inc.$291
  • Teva Pharmaceuticals USA, Inc.$291
  • Otsuka America Pharmaceutical, Inc.$247
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$143
  • plus $782 from 13 others

What the payments were for

  • Speaking & faculty fees$18,70083%
  • Travel & lodging$4902%
  • Food & beverage$3,29515%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,485 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl51$71,267
Aripiprazole140$11,046
Duloxetine Hcl106$3,082
Bupropion XlBupropion Hcl125$2,148
Quetiapine Fumarate138$1,980
Amitriptyline Hcl80$1,539
Hydroxyzine Hcl37$1,160
Venlafaxine Hcl ErVenlafaxine Hcl113$1,086
Fluoxetine Hcl25$993
Hydroxyzine Pamoate63$829
Buspirone Hcl72$745
Oxcarbazepine13$637
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$604
Gabapentin37$421
Alprazolam43$393

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$20,289$71,26751 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.

Other family in Rock Island

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →